CathWorks @CathWorks

Congratulations to Prof. Guy Witberg for presenting his latest real-world #FFRangio outcomes data at #TCT2024. In a real-world setting, FFRangio-guided treatment demonstrated excellent 2-year outcomes for both ACS and CCS patients, which are comparable with current data for wire-based FFR treatment. We’re grateful to Prof. Witberg for his ongoing contributions to evidence generation, and his efforts to redefine cardiovascular care. #TheNewEraInPhysiology #TCT2024

Humbled and honored to be able to share my passion for coronary physiology along with the luminaries, @MortonKern! Excited about having this innovative and disruptive technology at @MtnsideMedCtr! We are truly delivering tomorrow’s care - today. @RaminMousaviMBA @CathWorks

CathWorks @CathWorks

2 years ago

#TheNewEraInPhysiology is here. Don’t just take our word for it. Hear from the experts. #TCT2024 | @MortonKern | @DrAnkitKPatel | @shailsingh

0 2 7 1K 0

#TheNewEraInPhysiology is here. Don’t just take our word for it. Hear from the experts. #TCT2024 | @MortonKern | @DrAnkitKPatel | @shailsingh

Congratulations to Dr. Kazuhiro Dan for presenting his latest data comparing #FFRangio and IVUS measurements, showing excellent correlation between the two modalities with regards to lesion length and vessel diameters. We’re grateful to Dr. Dan for his ongoing contribution to evidence generation that will continue to drive the adoption of the FFRangio System. #TheNewEraInPhysiology #TCT2024

🎥Behind the scenes at #TCT2024! Stay tuned for the latest @CathWorks insights and updates. #TheNewEraInPhysiology

keyboard_arrow_left Previous keyboard_arrow_right Next

My #TCT2024 highlight today was the excellent session on coronary physiology: FFRangio in PROVISION, PPG, and iFR/FFR in ORBITA-2 @TCTConference @CCAD_MHIF @PedroEPCarvalho

keyboard_arrow_left Previous keyboard_arrow_right Next

Congratulations to Dr. @DrAllenJ, Dr. Ajay Kirtane, Prof. Hitoshi Matsuo, and Dr. @wfearonmd for a fantastic #TCT2024 lunchtime symposium that was standing room only! The audience was eager to learn about how the CathWorks #FFRangio System is bringing the benefits of angiography-based physiology to more cath labs around the globe. We are grateful for the partnership with these world-class KOLs as we transform how cardiovascular disease is diagnosed and treated. #ProudToBeCathWorks #TheNewEraInPhysiology

keyboard_arrow_left Previous keyboard_arrow_right Next

Congratulations to Prof. Hitoshi Matsuo for his presentation on the PROVISION Study today at #TCT2024, where the theatre was standing room only. Prof. Matsuo showed that the study met its primary endpoint and revealed significant economic and resource utilization advantages for the non-invasive #FFRangio technology compared to invasive wire-based FFR. Learn more from CathWorks' latest press release: cath.works/provision-stud… #TheNewEraInPhysiology #ExperienceTheNewEra

keyboard_arrow_left Previous keyboard_arrow_right Next

Today at the #TCT2024 conference, Professor Hitoshi Matsuo from Gifu Heart Center shared results from the PROVISION Study, the first RCT of FFRangio outcomes compared to invasive wire-based FFR. The study met its primary endpoint and revealed significant economic and resource utilization advantages for the non-invasive #FFRangio technology over traditional wire-based approaches. Read more: cath.works/provision-stud… #TheNewEraInPhysiology #PROVISION

We're all set at #TCT2024 and the exhibits are officially open! Come visit the CathWorks booth to experience #TheNewEraInPhysiology with a live demonstration from our talented team. Don't miss our symposium tomorrow at 12:15PM, where the expert panel will discuss how the #FFRangio System is redefining how coronary artery disease is diagnosed and treated. Stay tuned for the latest updates throughout the meeting! #ExperienceTheNewEra #TCT24

keyboard_arrow_left Previous keyboard_arrow_right Next

CathWorks announces key events for the annual TCT conference kicking off this weekend in Washington, DC. The CathWorks #FFRangio® System will be featured in multiple scientific presentations including the first ever prospective RCT comparing an angio-based physiology tool versus FFR in Japan. The FFRangio technology will also be showcased in an educational symposium with a world-renowned faculty, and will be available for hands-on peer-to-peer demonstrations during Meet the Expert sessions hosted by leading physicians in the CathWorks booth. Read more: cath.works/cathworks-anno…

We are thrilled to welcome Todd Christianson to CathWorks as a Territory Manager in Wisconsin! Todd brings over 20 years of experience in interventional cardiology medical device sales, with considerable expertise in coronary physiology and intravascular imaging. He has been instrumental in broadening the adoption of innovative cardiovascular technologies in his territory. We’re excited for Todd to leverage his expertise to bring the #FFRangio System to more physicians and patients as we continue to redefine how cardiovascular disease is diagnosed and treated. Welcome, Todd! #ProudToBeCathWorks #TheNewEraInPhysiology

Read how the CathWorks #FFRangio System is enhancing the way doctors at @AdventHealth detect and treat coronary artery disease, making procedures safer and less burdensome for patients. Dr. Dean Abtahi highlights, “This is about making sure we are treating patients in the safest and most effective way. CathWorks allows us to use fewer tools and medications, which means patients can recover quicker and with fewer complications.” Learn more: adventhealth.com/hospital/adven… #TheNewEraInPhysiology | @AdventHealthCFL | @AdventHealthWFL

The countdown is nearly over - #TCT2024 starts on Sunday! Join us in Washington, DC for a packed meeting, including a lunch symposium with expert faculty and scientific presentations featuring the #FFRangio System throughout the conference. Don’t miss your opportunity to #ExperienceTheNewEra in coronary physiology: cath.works/tct-2024/ #TheNewEraInPhysiology #TCT24

We are thrilled to welcome Robert Miller to CathWorks as the Territory Manager for Florida! Robert brings over 20 years of experience in interventional cardiology and cardiac surgery. His passion to transform cardiovascular care, combined with his extensive industry expertise, will be instrumental in driving the adoption of the #FFRangio System across his territory. We’re excited to have Robert onboard as we continue to redefine the future of cardiovascular disease from diagnosis to treatment. Welcome, Robert! #ProudToBeCathWorks #TheNewEraInPhysiology

Only 1️⃣0️⃣ days until #TCT2024! Join us in Washington, DC to hear expert faculty discuss how the #FFRangio System has redefined what a physiology solution can deliver in daily practice. Chair: Dr. Martin B. Leon Presenters: Dr. William F. Fearon , Prof. Hitoshi Matsuo, and Dr. Megha Prasad Register now: cath.works/tct-2024/ #TheNewEraInPhysiology #ExperienceTheNewEra #TCT24

Congratulations to Dr. @DrAnkitKPatel, and the entire team at @MtnsideMedCtr for achieving the significant accomplishment of performing 100 #FFRangio cases! We're grateful for the committed partnership with such a dedicated team as we continue to transform cardiovascular disease through the continuum of care. #ProudToBeCathWorks #TheNewEraInPhysiology | @ArdentHealth | @HMHNewJersey

keyboard_arrow_left Previous keyboard_arrow_right Next

Congratulations to Dr. @SFournierMD and the entire team at CHUV - Lausanne University Hospital in Switzerland for enrolling their first patient in the global ALL-RISE Study! We are grateful to partner with such a dedicated team and look forward to providing additional evidence to the clinical community establishing #FFRangio as the standard of care. #ALLRISEstudy #ProudToBeCathWorks